Norges Bank’s PRA Health Sciences, Inc. PRAH Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q3 | – | Sell |
-577,785
| Closed | -$95.5M | – | 2393 |
|
|
2021
Q2 | $95.5M | Sell |
577,785
-11,478
| -2% | -$1.9M | 0.02% | 668 |
|
|
2021
Q1 | $90.4M | Buy |
589,263
+9,890
| +2% | +$1.52M | 0.02% | 679 |
|
|
2020
Q4 | $72.7M | Buy |
579,373
+10,807
| +2% | +$1.36M | 0.02% | 747 |
|
|
2020
Q3 | $57.7M | Sell |
568,566
-46,635
| -8% | -$4.73M | 0.02% | 767 |
|
|
2020
Q2 | $59.9M | Sell |
615,201
-37,027
| -6% | -$3.6M | 0.02% | 727 |
|
|
2020
Q1 | $54.2M | Buy |
652,228
+18,148
| +3% | +$1.51M | 0.02% | 664 |
|
|
2019
Q4 | $70.5M | Buy |
634,080
+18,384
| +3% | +$2.04M | 0.02% | 705 |
|
|
2019
Q3 | $61.1M | Buy |
615,696
+56,738
| +10% | +$5.63M | 0.02% | 751 |
|
|
2019
Q2 | $55.4M | Sell |
558,958
-1,175
| -0.2% | -$117K | 0.02% | 808 |
|
|
2019
Q1 | $61.8M | Sell |
560,133
-18,683
| -3% | -$2.06M | 0.02% | 729 |
|
|
2018
Q4 | $53.2M | Hold |
578,816
| – | – | 0.02% | 712 |
|
|
2018
Q3 | $63.8M | Buy |
578,816
+37,779
| +7% | +$4.16M | 0.02% | 697 |
|
|
2018
Q2 | $50.5M | Sell |
541,037
-142,394
| -21% | -$13.3M | 0.02% | 825 |
|
|
2018
Q1 | $56.7M | Buy |
683,431
+83,555
| +14% | +$6.93M | 0.02% | 723 |
|
|
2017
Q4 | $54.6M | Sell |
599,876
-13,338
| -2% | -$1.21M | 0.02% | 749 |
|
|
2017
Q3 | $46.7M | Buy |
613,214
+49,017
| +9% | +$3.73M | 0.02% | 822 |
|
|
2017
Q2 | $42.3M | Buy |
564,197
+70,147
| +14% | +$5.26M | 0.02% | 856 |
|
|
2017
Q1 | $32.2M | Sell |
494,050
-274,119
| -36% | -$17.9M | 0.01% | 1027 |
|
|
2016
Q4 | $42.3M | Buy |
768,169
+345,000
| +82% | +$19M | 0.02% | 763 |
|
|
2016
Q3 | $22.8M | Hold |
423,169
| – | – | 0.01% | 1142 |
|
|
2016
Q2 | $17.7M | Buy |
423,169
+69,390
| +20% | +$2.9M | 0.01% | 1277 |
|
|
2016
Q1 | $15.1M | Buy |
353,779
+201,642
| +133% | +$8.62M | 0.01% | 1331 |
|
|
2015
Q4 | $6.89M | Buy |
152,137
+127,597
| +520% | +$5.78M | ﹤0.01% | 1778 |
|
|
2015
Q3 | $953K | Buy |
+24,540
| New | +$953K | ﹤0.01% | 2120 |
|